Max Roessler
Impact in
-
- NF-κB Signaling Pathways
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 2
- Neutropenia and Cancer Infections 2
-
- Lung Cancer Treatments and Mutations 3
- Gastric Cancer Management and Outcomes 1
- Co-authors
- Robert Zeillinger (2 shared papers)Sandra Tomek (2 shared papers)Michael Krainer (2 shared papers)Dietmar Pils (2 shared papers)Christoph Zielinski (2 shared papers)Peter Horak (2 shared papers)Ingrid Pribill (1 shared paper)Reinhard Horvat (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Tumor Biology (2 papers)Molecular Cancer Research (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Clinical Colorectal Cancer (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Max Roessler
11 papers receiving 233 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 58
- Oncology 91
- Molecular Biology 153
- Immunology 46
- Toxicology 4
Countries citing papers authored by Max Roessler
This map shows the geographic impact of Max Roessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Roessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Roessler more than expected).
Fields of papers citing papers by Max Roessler
This network shows the impact of papers produced by Max Roessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Roessler. The network helps show where Max Roessler may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Roessler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 122 | |
| 2 | 2016 | 54 | |
| 3 | 2017 | 19 | |
| 4 | 2005 | 18 | |
| 5 | 1967 | 9 | |
| 6 | 2016 | 4 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 3 | |
| 9 | 2017 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 1 |
About Max Roessler
Max Roessler is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Aerospace Engineering, having authored 11 papers that have together received 238 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cell death mechanisms and regulation (2 papers), Neutropenia and Cancer Infections (2 papers) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Cancer Research (58 citations), Oncology (91 citations), Molecular Biology (153 citations), Immunology (46 citations) and Toxicology (4 citations). Max Roessler has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Robert Zeillinger, Sandra Tomek, Michael Krainer, Dietmar Pils, Christoph Zielinski, Peter Horak, Ingrid Pribill, Reinhard Horvat, Ulrich Jaehde and Berta Moritz. Their work appears in journals such as Journal of Clinical Oncology, Tumor Biology, Molecular Cancer Research, CPT Pharmacometrics & Systems Pharmacology and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.